• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Wanbury Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • PPI
  • BSE Code : 2393.0
  • ISIN : INE107F01022
239.35 -2 (-0.87%)
  • As on 14 Sep 2026 (EOD)

  • Today’s Low

    234.75

  • Today’s High

    240.40

  • Open

    240.00

  • Perv Close

    241.45

  • 52W Low

    161.50

  • 52W High

    358.85

Key Indicators

  • P/E(TTM)

    14.11

  • Mar.Cap (₹Cr.)

    836.93

  • Div & Yield %

    0.00

  • Book Value(₹)

    41.32

  • Debt-Equity Ratio

    -0.87

  • AGM Date

    11-Sep-2026

  • EPS

    16.97

  • P/E Ratio

    14.11

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    836.93

  • RONW (%)

    49.77

  • ROCE (%)

    33.46

Score Board

  • Equity (₹ in Cr.)

    34.97

  • BV (₹)

    41.30

  • Sales( ₹ in Cr.)

    650.27

  • NP (in Cr.)

    69.66

  • NP Var(%)

    145.0

  • Div%

    0.0

  • CPS (₹)

    24.00

  • EPS (₹)

    19.90

  • Traded Value (₹ in Lakhs)

    837.46

  • 52 Week High

    358.85

  • 52 Week Low

    161.50

  • Price BSE

    240.0

  • Price NSE

    239.00

  • Market Capital( in Cr.)

    837.46

  • P/C Ratio

    10.00

  • P/E Ratio

    12.00

  • Price Vs.BV

    19.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 650.27 599.51 577.74 499.65 511.19 392.52
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 650.27 599.51 577.74 499.65 511.19 392.52
Other Income 0.94 3.49 0.90 0.91 77.88 2.40
Stock Adjustments 13.00 -1.51 3.89 -29.13 24.79 7.20
Total Income 664.21 601.49 582.53 471.43 613.86 402.12
EXPENDITURE :            
Raw Materials 289.51 292.96 307.48 274.31 325.07 228.53
Power and Fuel Cost 28.59 24.24 25.17 20.59 18.41 17.13
Employee Cost 119.64 101.56 86.92 81.00 74.81 64.15
Other Manufacturing Expenses 13.63 13.76 13.32 11.43 12.66 9.98
Selling and Administration Expenses 75.68 65.92 58.71 45.16 55.34 45.49
Miscellaneous Expenses 33.07 23.15 17.93 15.45 14.36 16.42
Employee Benefit Expenses 119.64 101.56 86.92 81.00 74.81 64.15
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 560.12 521.58 509.54 447.94 500.65 381.70
Operating Profit 104.10 79.91 72.99 23.49 113.19 20.42
Interest 29.98 36.95 29.18 21.39 20.61 23.07
Gross Profit 74.12 42.96 43.81 2.10 92.58 -2.65
Depreciation 14.31 13.41 13.03 12.38 11.45 9.75
Profit Before Tax 59.81 29.55 30.78 -10.28 81.13 -12.40
Current Tax 0.65 5.86 0.00 0.00 0.00 2.27
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -6.98 -6.84 0.38 0.11 -0.35 -2.07
Reported Net Profit 66.13 30.53 30.40 -10.40 81.47 -12.61
Extraordinary Items -3.53 2.05 0.49 -0.31 76.06 1.21
Adjusted Net Profit 69.66 28.48 29.91 -10.09 5.41 -13.82
Adjustment below Net Profit -0.56 -0.38 -0.59 0.26 0.80 -0.44
P & L Balance brought forward -108.17 -138.34 -168.14 -158.01 -240.28 -227.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -42.60 -108.19 -138.34 -168.14 -158.01 -240.28
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 18.93 9.32 9.28 -3.18 24.94 -5.04
Earnings Per Share(Adj)-Unit Curr 18.93 9.32 9.28 -3.18 24.94 -5.04
Book Value 41.34 16.26 6.70 -2.26 0.57 -52.23
Book Value(Adj)-Unit Curr 41.34 16.26 6.70 -2.26 0.57 -52.23

Shareholding Pattern

  • Promoter Group

    43.02%

  • Public Share Holding

    56.98%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,024,000 8.66 3,024,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 12,005,561 34.36 12,005,561 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,005,561 34.36 12,005,561 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 521 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 312,390 0.89 312,390 6
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 856 0.00 856 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 20,118 0.06 20,118 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 333,885 0.96 333,364 12
2] Non Institution
Bodies Corporate 2,077,478 5.95 2,076,275 158
Clearing Members 136,657 0.39 136,657 36
Directors of their Relatives 0 0.00 0 0
Employees 52,600 0.15 52,600 1
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 647,317 1.85 645,198 288
Foreign Non Institution Other 94,680 0.27 0 1
Hindu Undivided Families 951,683 2.72 951,617 502
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,389,897 21.15 7,389,897 84
Individuals holding nominal share capital up to Rs. 1 lakh 7,252,823 20.76 7,130,432 16,062
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 469,615 1.34 469,615 6
Sub Total 19,575,952 56.03 19,355,413 17,160
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 34,939,398 100.00 34,718,338 17,174

Company Background

Wanbury LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Wanbury Ltd
  • BSE Code : 2393.0
  • ISIN : INE107F01022

  • Incorporation Year

    1988

  • Registered Office

    BSEL Tech Park B-Wing 10th Flr
    Sector 30 A Opp Vashi Rly Stat, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-67942222

  • FAX

    91-22-67942111/333

  • Chairman

  • Managing Director

  • Company Secretary

    Jitendra J Gandhi

  • Auditor

    Kapoor & Parekh Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Wanbury Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Wanbury 239.50 651.21 650.27 14.99 22.40
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77